- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05011968
Intervention Study on Iodine Biofortification Vegetables ( Nutri-I-Food (Nutri-I-Food)
Intervention Study With Crop Lettuce Enriched With Iodine
Study Overview
Status
Conditions
Detailed Description
Several human pathologies are caused by deficiencies of some mineral elements. These deficiencies can be overcome through careful dietary diversification and mineral supplementation. An alternative or even complementary way is represented by the intake of bio-fortified foods. In the field of mineral deficiency increasing the bioavailable mineral concentration in vegetables intended for human consumption; can be a useful tool to prevent many harmful pathologies. Therefore, in this scenario, it appears very important to identify the right dosages and the most effective methods of administration to bio-fortify vegetables with a strong nutritional-health connotation.
The present project aim to investigate the benefits of fortified food intake in a cohort of healthy individuals. Specifically, healthy individuals received lettuce enriched with iodine and after 10 days plasma and urine samples were collected . Each subject was subjected to two venous blood samples taken at the beginning of the observation and at the end (after 10 days). The samples thus obtained were transported in certified containers for the safe transport of biological samples, and, subsequently, processed by the laboratories of the Molecular Biology section of the University of Palermo. Serum and plasma will be obtained from each blood sample. All information thus obtained will be recorded in a database in which each person will be identified with a numerical code, in order to comply with current privacy regulations. Body weight, Barefoot standing height, Body mass index, Body composition will be measured in the different groups of study. Samples will be analyzed and compared for glucose, albumin, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, uric acid, creatinine, AST, ALT, γ-GT, ALP, bilirubin, Ferritin, free Iron, transferrin, total proteins, Magnesium, Calcium, insulin, osteocalcin,TSH, FT3, FT4, hematocrit, hs-CRP, Bone metabolism (Osteocalcin, parathyroid hormone, CTX, Calcitonin), Vitamin D Calcium, Phosphate, Potassium, gastric hormones ( GIP, GLP1, GLP2, ghrelin, glucagon, PYY, CCK) oxidative stress markers (LDL-ox, AGE, urinary 8-iso-prostaglandin F (PGF)2alpha) and inflammatory markers(IL-1, TNF, IL-6, IL-10)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Palermo, Italy, 90141
- Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, Palermo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Caucasian
- age: 18-65 years
- healthy status
- no drug therapy or integration therapy
Exclusion Criteria:
- Inflammatory chronic disease
- use of medication or suffering from any condition
- pregnancy
- breastfeeding
- current smokers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: No Intervention: (control group)
The control group was assigned to crop lettuce without any biofortification but with the same characteristic of bioforticated lettuce (soil, water, harvesting time)
|
Lettuce without any biofortification was assigned to each participant belonging to the control group which ate 100gr every day for 10 days
|
|
Experimental: Experimental: intervention group
The intervention group was assigned to biofortificated Iodine crop lettuce.
|
Lettuce with Iodine biofortification was assigned to each participant belonging to the intervention group which ate 100gr every day for 10 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum Thyroid markers
Time Frame: 10 days
|
serum levels of free tri-iodothyronine (FT3 ng/L), free thyroxine (FT4 ng/L) and thyroid-stimulating hormone (TSH ng/L) will be assessed at baseline and after 10 days
|
10 days
|
|
Urine Iodine concentration
Time Frame: 10 days
|
Urine Iodine concentration (mg/l) will be assessed at baseline and after 10 days
|
10 days
|
|
Haematology and serum chemistry values 1
Time Frame: 10 days
|
glucose (mg/dL), albumin( mg/dL), total cholesterol (mg/dL), HDL-cholesterol (mg/dL), LDL-cholesterol (mg/dL), triglycerides(mg/dL), uric acid(mg/dL), creatinine(mg/dL) will be assessed at baseline and after 10 days
|
10 days
|
|
Haematology and serum chemistry values 2
Time Frame: 10 days
|
insulin (mUI/L) will be assessed at baseline and after 10 days
|
10 days
|
|
Haematology and serum chemistry values 3
Time Frame: 10 days
|
Potassium (mmol/L) will be assessed at baseline and after 10 days
|
10 days
|
|
Haematology and serum chemistry values 4
Time Frame: 10 days
|
Ferritin (mg/L), free Iron (mg/L), transferrin (mg/L), total proteins (mg/L), Magnesium (mg/L), Calcium (mg/L), Vitamin D (mg/L), HCRP (mg/L), Phosphate (mg/L), Cortisol (mg/L)will be assessed at baseline and after 10 days
|
10 days
|
|
Haematology and serum chemistry values 5
Time Frame: 10 days
|
AST (U/L), ALT (U/L), γ-GT(U/L), ALP(U/L) will be assessed at baseline and after 10 days
|
10 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inflammatory markers
Time Frame: 10 days
|
IL-1 (pg/mL), TNF(pg/mL), IL-6(pg/mL), IL-10(pg/mL) measured in plasma will be assessed at baseline and after 10 days
|
10 days
|
|
body mass index (BMI)
Time Frame: 10 days
|
BMI (kg/m2) All these measurements will be assessed at baseline and after 10 days
|
10 days
|
|
body composition (%)
Time Frame: 10 days
|
lean mass as percent of body weight and fat mass as percent of body weight will be assessed at baseline and after 10 days
|
10 days
|
|
Gastric Hormones
Time Frame: 10 days
|
GIP (pg/m), GLP1 (pg/m), GLP2 (pg/m), ghrelin (pg/m), glucagon (pg/m), PYY (pg/m), CCK(pg/m) measured in plasma will be assessed at baseline and after 10 days
|
10 days
|
|
Oxidative stress markes
Time Frame: 10 days
|
LDL-ox (ug/mL), AGE(ng/mL), urinary 8-iso-prostaglandin F (PGF)2alpha (ng/mL) will be assessed at baseline and after 10 days
|
10 days
|
|
Bone metabolism
Time Frame: 10 days
|
Osteocalcin(ng/L), parathyroid hormone (ng/L), CTX, Calcitonin (ng/L) measured in plasma will be assessed at baseline and after 10 days
|
10 days
|
|
Weigh
Time Frame: 10 days
|
Weight (Kg) will be assessed at baseline and after 10 days
|
10 days
|
|
Hight
Time Frame: 10 days
|
Hight (m) will be assessed at baseline and after 10 days
|
10 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sonya Vasto, PhD, D. Biological, Chemical and Pharmaceutical Sciences and Technologies, Palermo University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Nutr-I-Food2019
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Individuals
-
USDA Grand Forks Human Nutrition Research CenterRecruiting
-
Universidade Federal de PernambucoRecruitingHealthy IndividualsBrazil
-
University of British ColumbiaRecruiting
-
University of British ColumbiaCompletedHealthy IndividualsCanada
-
Dr. Anuradha KhadilkarTATA TrustsCompleted
-
Dokuz Eylul UniversityCompletedHealthy IndividualsTurkey
-
Singapore Institute of TechnologyCompletedHealthy IndividualsSingapore
-
University Hospital, BonnCompleted
-
University of Sao PauloCompleted
-
Haute Ecole Bruxelles-BrabantCompletedHealthy | Healthy Individuals (Controls)Belgium
Clinical Trials on Lettuce with not biofortification
-
University of PalermoCompleted
-
University of PalermoCompleted
-
The Catholic University of KoreaCompleted
-
Hospital Moinhos de VentoActive, not recruitingCOVID-19 | Quality of Life | Disability Physical | Disabilities MentalBrazil
-
Pôle Saint HélierINSA RennesCompleted
-
Pôle Saint HélierINSA RennesCompletedNeurological DisorderFrance
-
Pôle Saint HélierCompletedNeurological DisordersFrance
-
University of Sao PauloFederal University of São Paulo; Universidade do Oeste PaulistaRecruiting
-
Shanghai Zhongshan HospitalRecruitingST-segment Elevation Myocardial Infarction (STEMI)China
-
University of MiamiCompletedDiabetes Mellitus, Type 1United States